Artículos por temáticas

Link between neurodevelopmental disorders and suicidal risk in children

Lévy-Bencheton J, Chaste P, Sansen M.

Encephale. 2025 Feb;51(1):39-45. doi: 10.1016/j.encep.2023.12.002. Epub 2024 Mar 23.

Pathogenic variants in chromatin-related genes: Linking immune dysregulation to neuroregression and acute neuropsychiatric disorders

Dale RC, Mohammad S, Han VX, Nishida H, Goel H, Tangye SG, Hollway G, Tantsis E, Gill D, Patel S; Chromatin Immune‐Brain Group.

Dev Med Child Neurol. 2025 Feb 22. doi: 10.1111/dmcn.16276. Online ahead of print.

Effects of acupuncture combined with bone-setting therapy to treat tourette syndrome: a three-arm randomized controlled trial

Jiawang L, Lingqing J, Jianchang L, Boxu L.

J Tradit Chin Med. 2025 Feb;45(1):176-183. doi: 10.19852/j.cnki.jtcm.2025.01.017.

Tumor-initiating and metastasis-initiating cells of clear-cell renal cell carcinoma

Pham DX, Hsu T.

J Biomed Sci. 2025 Feb 8;32(1):17. doi: 10.1186/s12929-024-01111-9.

The thalamus: Structure, function, and neurotherapeutics

Marcuse LV, Langan M, Hof PR, Panov F, Saez I, Jimenez-Shahed J, Figee M, Mayberg H, Yoo JY, Ghatan S, Balchandani P, Fields MC.

Neurotherapeutics. 2025 Feb 15:e00550. doi: 10.1016/j.neurot.2025.e00550. Online ahead of print.

Genetic advances and translational phenotypes in rodent models for Tourette disorder

Kowalski TF, Wang R, Tischfield MA.

Curr Opin Neurobiol. 2025 Feb;90:102967. doi: 10.1016/j.conb.2024.102967. Epub 2025 Jan 9.

Safety and Efficacy of Ecopipam in Patients with Tourette Syndrome: A Systematic Review and Meta-analysis

Panda PK, Panda P, Dawman L, Mishra AS, Kumar V, Sharawat IK.

CNS Drugs. 2025 Feb;39(2):127-142. doi: 10.1007/s40263-024-01140-w. Epub 2024 Dec 27.

Premonitory urge in tic disorders - a scoping review

Wohlgemuth JB, Watson KH, Gill KD, Isaacs DA.

Front Psychiatry. 2025 Jan 30;16:1504442. doi: 10.3389/fpsyt.2025.1504442. eCollection 2025.

KSR1 mediates small-cell lung carcinoma tumor initiation and cisplatin resistance

Chatterjee D, Svoboda RA, Huisman DH, Drapkin BJ, Vieira HM, Rao C, Askew JW, Fisher KW, Lewis RE.

bioRxiv [Preprint]. 2025 Jan 31:2024.02.23.581815. doi: 10.1101/2024.02.23.581815.

Role and related mechanisms of non-invasive brain stimulation in the treatment of Tourette syndrome

Liang B, Zhou Y, Jiang C, Zhao T, Qin D, Gao F.

Brain Res Bull. 2025 Feb 13;222:111258. doi: 10.1016/j.brainresbull.2025.111258. Online ahead of print.

Pain in Tourette Syndrome: A Comprehensive Review

Green B, Waters A, Jimenez-Shahed J.

J Child Adolesc Psychopharmacol. 2025 Feb;35(1):23-36. doi: 10.1089/cap.2024.0025. Epub 2024 Nov 19.

Editorial: Placebo Response in Child and Adolescent Psychiatry: To Mitigate or to Harness?

Singh MK.

J Am Acad Child Adolesc Psychiatry. 2025 Jan 31:S0890-8567(25)00054-1. doi: 10.1016/j.jaac.2025.01.024. Online ahead of print.

Function-Specific Localization in the Supplementary Motor Area: A Potential Effective Target for Tourette Syndrome

Wang J, Yue J, Wang Y, Li XL, Deng XP, Lou YT, Gao LY, Chen XQ, Su QY, Zang YF, Feng JH.

CNS Neurosci Ther. 2025 Feb;31(2):e70280. doi: 10.1111/cns.70280.

Aripiprazole Therapy and CYP2D6 Genotype

Dean L, Kane M.

2016 Sep 22 [updated 2025 Jan 17]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.

Correspondence regarding "Letter to the editor: TMS-evoked potentials provide novel neurophysiological features of Tourette syndrome"

Anis S.

Parkinsonism Relat Disord. 2025 Jan 9:107269. doi: 10.1016/j.parkreldis.2025.107269. Online ahead of print.